XENE · Xenon Pharmaceuticals Inc. · Documents
$35.97
+0.89 (+2.54%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$3.51B
Shares
96.84M
Volume · Oct 20
313.87K
Avg daily vol (3M)
1.42M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-09 | 2026-09-30 | |
| 8-K | — | 2026-08-06 | — | |
| 10-Q | — | 2026-08-06 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-06-04 | 2026-06-30 | |
| 8-K | — | 2026-06-03 | 2026-06-02 | |
| Investor Event Transcript | — | 2026-05-19 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-14 | 2026-06-30 | |
| 8-K | — | 2026-05-07 | — | |
| 10-Q | — | 2026-05-07 | 2026-03-31 | |
| DEFA14A | — | 2026-04-22 | — | |
| ARS | — | 2026-04-22 | 2025-12-31 | |
| DEF 14A | — | 2026-04-22 | — | |
| Investor Event Transcript | — | 2026-04-22 | 2026-06-30 | |
| 8-K | — | 2026-04-13 | 2026-04-07 | |
| 8-K | — | 2026-03-13 | — | |
| 8-K | — | 2026-03-12 | 2026-03-10 | |
| 8-K | — | 2026-03-09 | — | |
| 8-K | — | 2026-02-27 | — | |
| 8-K | — | 2026-02-26 | — | |
| 10-K | — | 2026-02-26 | 2025-12-31 | |
| 8-K | — | 2025-12-01 | 2025-11-24 | |
| 8-K | — | 2025-11-03 | — | |
| 10-Q | — | 2025-11-03 | 2025-09-30 | |
| 8-K/A | — | 2025-10-17 | 2025-10-15 | |
| 8-K | — | 2025-10-16 | 2025-10-15 | |
| 10-Q | — | 2025-08-11 | 2025-06-30 | |
| 8-K | — | 2025-08-11 | — | |
| 8-K | — | 2025-07-03 | 2025-06-30 | |
| 8-K | — | 2025-06-05 | 2025-06-04 | |
| 8-K | — | 2025-05-12 | — | |
| 10-Q | — | 2025-05-12 | 2025-03-31 | |
| DEF 14A | — | 2025-04-24 | — | |
| DEFA14A | — | 2025-04-24 | — | |
| ARS | — | 2025-04-24 | 2024-12-31 | |
| 8-K | — | 2025-03-17 | 2025-03-14 | |
| 8-K | — | 2025-03-05 | 2025-03-03 | |
| 10-K | — | 2025-02-27 | 2024-12-31 | |
| 8-K | — | 2025-02-27 | 2025-02-24 | |
| 8-K | — | 2025-01-17 | — | |
| 10-Q | — | 2024-11-12 | 2024-09-30 | |
| 8-K | — | 2024-11-12 | — | |
| S-3ASR | — | 2024-08-09 | — | |
| 10-Q | — | 2024-08-08 | 2024-06-30 | |
| 8-K | — | 2024-08-08 | — | |
| 8-K | — | 2024-06-05 | 2024-06-04 | |
| 10-Q | — | 2024-05-09 | 2024-03-31 | |
| 8-K | — | 2024-05-09 | — | |
| DEF 14A | — | 2024-04-26 | — | |
| ARS | — | 2024-04-26 | 2023-12-31 | |
| 8-K | — | 2024-04-19 | 2024-04-15 |
Showing 1–50 of 128 filings
Key facts
CIK
1582313
CUSIP
98420N105
13F (30d)
15 filings
15 filers
Visit website
Investor relations